Singh, D., Balaguer, V., Astbury, C., Wählby-Hamrén, U., Jimenez, E., Seoane, B., . . . Psallidas, I. (2020). Navafenterol (AZD8871) in patients with COPD: A randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator. Respir Res.
Citação norma ChicagoSingh, Dave, et al. "Navafenterol (AZD8871) in Patients With COPD: A Randomized, Double-blind, Phase I Study Evaluating Safety and Pharmacodynamics of Single Doses of This Novel, Inhaled, Long-acting, Dual-pharmacology Bronchodilator." Respir Res 2020.
Citação norma MLASingh, Dave, et al. "Navafenterol (AZD8871) in Patients With COPD: A Randomized, Double-blind, Phase I Study Evaluating Safety and Pharmacodynamics of Single Doses of This Novel, Inhaled, Long-acting, Dual-pharmacology Bronchodilator." Respir Res 2020.